Key facts
- Medarca’s last known valuation is $5.8M (Jan 2024).
- It has raised $3.1M; the latest was PE Growth/Expansion ($450K) in Feb 2025.
- Notable investors include Almi Invest, Medeon Science Park, Queen Invest, Sandberg Development.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Medarca
- ·The full record, as it builds
Funding rounds
No funding rounds for Medarca are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medarca
Developer of a medical handling system designed to automatically check and manage medicine usage. The company's system consists of hardware that physically handles the medications, as well as checks that those medications are handled properly without any administration, enabling its clients to reduce the wastage of drugs through efficient inventory management.
- Sector
- Healthcare
- HQ
- Malmo, Sweden
- Founded
- 2018
- Employees
- 10
- Website
- medarca.com/
- Ownership
- Privately Held (backing)
Medarca doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medarca shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medarca in its N-PORT filings yet. We sweep new filings monthly.